Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: A retrospective study and a prospective, randomized trial

Pediatric Critical Care Medicine

Volumn 8, Issue 6, 2007, Pages 556-562

  Filippi, Luca ^a   Pezzati, Marco ^b   Di Amario, Simona ^a   Poggi, Chiara ^a   Pecile, Patrizia ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Bloodstream infection; Central venous catheter; Fusidic acid; Nosocomial infection; Premature infants; Sepsis

Indexed keywords

AMOXICILLIN; FLUCONAZOLE; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; HEPARIN; LINEZOLID; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; DEMOGRAPHY; DRUG COST; DRUG EFFICACY; HUMAN; INTENSIVE CARE UNIT; LEUKOPENIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDEROBLASTIC ANEMIA; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA;

EID: 35949002444     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000288711.46009.58     Document Type: Article

References (46)

1. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al: Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 2001; 139:821-827
2. Rello J, Ochagavia A, Sabanes E, et al: Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-1230
3. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections. Pediatrics 2002; 110:e51-e74
4. Garland JS, Henrickson K, Maki DG: The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for prevention of intravascular device-related infection. Pediatrics 2002; 110:1009-1013
5. Garland JS, Alex CP, Henrickson KJ, et al: A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: A prospective, randomized trial. Pediatrics 2005; 116:e198-e205
6. Thylefors JD, Harbarth S, Pittet D: Increasing bacteremia due to coagulase-negative staphylococci: Fiction or reality? Infect Control Hosp Epidemiol 1998; 19:581-589
7. Gray JE, Richardson DK, McCormick MC, et al: Coagulase-negative staphylococcal bacteremia among very low birth weight infants: Relation to admission illness severity, resource use, and outcome. Pediatrics 1995; 95:225-230
8. Carratalà J: The antibiotic-lock technique for therapy of "highly needed" infected catheters. Clin Microbiol Infect 2002; 8:282-289
9. Messing B, Peitra-Cohen S, Debure A, et al: Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988; 12:185-189
10. Capdevila JA, Gavalda J, Pahissa A: Antibiotic-lock technique: Usefulness and controversies. Antimicrob Infect Dis News 1996; 15:9-16
11. Carratalà J, Niubo J, Fernandez-Sevilla A, et al: Randomized, double-bind trial of an antibiotic-lock technique for prevention of Gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43:2200-2204
12. Huebner J, Kropec A, Engels I, et al: In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid. Chemotherapy 1992; 38:206-210
13. Samra Z, Ofer O, Shmuely H: Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Isr Med Assoc J 2005; 7:148-150
14. Shanson DC: Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. J Antimicrob Chemother 1990; 25(Suppl B):15-21
15. Goodwin AW, Rich GE, Tynan MJ: Fusidic acid in staphylococcal infection. Lancet 1973; 2:1504-1505
16. Fallat ME, Gallinaro RN, Stover BH, et al: Central venous catheter bloodstream infections in the neonatal intensive care unit. J Pediatr Surg 1998; 33:1383-1387
17. Garland JS, Alex CP, Mueller CD, et al: A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107:1431-1436
18. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. Villanova, PA, National Committee for Clinical Laboratory Standards, 1993
19. Mahieu LM, De Dooy JJ, Lenaerts AE, et al: Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. J Hosp Infect 2001; 48:20-26
20. Gristina AG, Jennings RA, Naylor PT, et al: Comparative in vitro antibiotic resistance of surface colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother 1989; 33:813-816
21. Raad I, Costerton W, Sabharwal U, et al: Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400-407
22. Pascual A, Ramirez de Arellano E, Martinez Martinez L, et al: Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobial agents against Staphylococcus epidermidis. J Hosp Infect 1993; 24:211-218
23. Gaillard JL, Merlino R, Pajot N, et al: Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 1990; 14:593-597
24. Messing B: Catheter-sepsis during home parenteral nutrition: Use of the antibiotic-lock technique. Nutrition 1998; 14:466-468
25. Johnson DC, Johnson FL, Goldman S: Preliminary results treating persistent central venous catheter infections with the antibiotic-lock technique in pediatric patients. Pediatr Infect Dis 1994; 13:930-931
26. Andris DA, Krzywda EA, Edmiston CE, et al: Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 1998; 14:427-432
27. Capdevila JA, Segarra A, Planes AM, et al: Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993; 8:231-234
28. Domingo P, Fontanet A, Sanchez F, et al: Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin Infect Dis 1999; 29:346-351
29. Krishnasami Z, Carlton D, Bimbo L, et al: Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61:1136-1142
30. Schwartz C, Henrickson KJ, Roghmann K, et al: Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8:1591-1597
31. Barriga FJ, Varas M, Potin M, et al: Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients Med Pediatr Oncol 1997; 28:196-200
32. Henrickson KJ, Axtell RA, Hoover SM, et al: Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, doublebind trial. J Clin Oncol 2000; 18:1269-1278
33. Raad I, Hachem R, Tcholakian RK, et al: Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 2002; 46:327-332
34. Dogra GK, Herson H, Hutchison B, et al: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 2002; 13:2133-2139
35. Allon M: Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36:1539-1544
36. Spafford PS, Sinkin RA, Cox C, et al: Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994; 125:259-263
37. Kacica MA, Horgan MJ, Ochoa L, et al: Prevention of Gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994; 125:253-258
38. Ocete E, Ruiz-Extremera A, Goicoechea A, et al: Low-dosage prophylactic vancomycin in central-venous catheters for neonates. Early Hum Dev 1998; 53(Suppl):S181-186
39. Anthony TU, Rubin LG: Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 1999; 43:2074-2076
40. Verbist L: The antimicrobial activity of fusidic acid. J Antimicrob Chemother 1990; 25(Suppl B):1-5
41. Schelonka RL, Freij BJ, McCracken GH Jr: Bacterial and fungal infections. In: Avery's Neonatology: Pathophysiology and Management of the Newborn. Sixth Edition. MacDonald MG, Seshia MM, Mullet MD (Eds). Philadelphia, Lippincott William & Wilkins, 2005, 1235-1273
42. Bertini G, Perugi S, Dani C, et al: Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 2005; 147:162-165
43. Inglis GD, Davies MW: Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters. Cochrane Database Syst Rev 2005; (4):CD005251
44. Liao YM, Chiu CF, Ho MW, et al: Fusidic acid-induced leukopenia and thrombocytopenia. J Chin Med Assoc 2003; 66:429-432
45. Vial T, Grignon M, Daumont M, et al: Sideroblastic anaemia during fusidic acid treatment. Eur J Haematol 2004; 72:358-360
46. Brodersen R: Fusidic acid binding to serum albumin and interaction with binding of bilirubin. Acta Paediatr Scand 1985; 74:874-880